Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type (1 selected)

Type

Guidance programme

Showing 926 to 950 of 2013

Published guidance, NICE advice and quality standards
TitleReference numberPublishedLast updated
Ibrutinib with rituximab for treating Waldenstrom's macroglobulinaemia (terminated appraisal)TA608
Ramucirumab for treating unresectable hepatocellular carcinoma after sorafenib (terminated appraisal)TA609
Gastro-oesophageal reflux disease and dyspepsia in adults: investigation and managementCG184
Rivaroxaban for preventing atherothrombotic events in people with coronary or peripheral artery diseaseTA607
End of life care for adults: service deliveryNG142
Lanadelumab for preventing recurrent attacks of hereditary angioedemaTA606
Midcarpal hemiarthroplasty for wrist arthritisHTG529
Diabetic foot problems: prevention and managementNG19
Voretigene neparvovec for treating inherited retinal dystrophies caused by RPE65 gene mutationsHST11
Gastro-oesophageal reflux disease in children and young people: diagnosis and managementNG1
Xeomin (botulinum neurotoxin type A) for treating chronic sialorrhoeaTA605
EXOGEN ultrasound bone healing system for long bone fractures with non-union or delayed healingHTG296
Familial hypercholesterolaemia: identification and managementCG71
Idelalisib for treating refractory follicular lymphomaTA604
Cellulitis and erysipelas: antimicrobial prescribingNG141
Pomalidomide with bortezomib and dexamethasone for treating relapsed or refractory multiple myeloma (terminated appraisal)TA602
Lenalidomide with bortezomib and dexamethasone for untreated multiple myeloma (terminated appraisal)TA603
High-intensity focused ultrasound for glaucomaHTG527
Bioprosthetic plug insertion for anal fistulaHTG528
Tegaderm CHG securement dressing for vascular access sites in critically ill adultsHTG379
Attention deficit hyperactivity disorder: diagnosis and managementNG87
Implant insertion for prominent earsHTG526
Benralizumab for treating severe eosinophilic asthmaTA565
Risankizumab for treating moderate to severe plaque psoriasisTA596
Patisiran for treating hereditary transthyretin amyloidosisHST10

Results per page

  1. 10
  2. 25
  3. 50
  4. All